FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live JUBILANT message board: Is JUBILANT buy or sell? Should I buy JUBILANT shares? Why are JUBILANT shares falling? Should I invest in JUBILANT stock?

forum

JUBILANT Share Price Discussion

Jubilant Life Sciences Ltd.
NSE: JUBILANT | BSE: 530019 | ISIN: INE700A01033 | Sector: Pharmaceuticals and health care
N
Reputation: 4,625 • Jun 23 10:36 AM
Dassault Systèmes demonstrates innovations for the life sciences industry in India
The event focused on transforming and digitalizing the life sciences industry in India, which is undergoing core shifts in business processes and manufacturing operations to make it more agile and adaptable.
The Economic Times
Like
Reply
NSE:JUBILANT price when posted: 672.5
Recent posts in JUBILANT
N
Reputation: 4,625 • Jul 31 1:53 AM
Remdesivir shortage to ease in August as existing suppliers boost capacity, new manufacturers enter
Around 8 lakh doses are expected to be available in the country in August as new manufacturers are getting ready to enter the market with their generic versions.
Moneycontrol
Like
Reply
M
Reputation: 77,939 • Jul 31 5:56 AM

Type
Buy
Instrument
JUBILANT
Entry Price
₹815
Price@Trade
₹803.15
Target Price
₹900
Stop Price
₹795
Valid Till
Jul 31, 2020 3:20 AM
Margin
₹81,500 approx for 100 Qty
Status
Exited before entry
Like
Reply (1)
C
Reputation: -9 • Jul 30 7:19 AM

Type
Buy
Instrument
JUBILANT
Entry Price
₹787
Price@Trade
₹787
Target Price
₹793
Stop Price
₹784.5
Valid Till
Jul 30, 2020 3:20 AM
Margin
₹78,700 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹784.5
Net P&L
-₹250 (-0.32%)
Like
Reply (1)
N
Reputation: 4,625 • Jul 30 2:28 AM
Trade Spotlight: Dr Reddy’s, IndusInd Bank, Nestle, Maruti and Jubilant Life in focus
Indian market witnessed profit-taking at higher levels on Wednesday and the trend is likely to remain volatile on Thursday as well ahead of June F&O expiry.
Moneycontrol
Like
Reply

JUBILANT - chart - 1088729
Buy JUBILANT@770 Tg. 810/1490 CB SL 650
Like
Reply
N
Reputation: 4,625 • Jul 29 3:08 AM
Dr Reddy's expects to launch Remdesivir in August
On another antivral Favipiravir, which is prescribed for mild COVID-19 cases, Dr Reddy's said it will be going ahead with the product, despite Glenmark's clinical trial data hasn't been statistically significant.
Moneycontrol
Like
Reply